Glenn Reicin

Glenn Reicin

Nessuna posizione attualmente
61 anni
Finance
Health Technology
Consumer Services

Profilo

Glenn M.
Reicin
served as Managing Director at Morgan Stanley & Co. LLC from 1993 to 2008.
Director roles were held at Novasys Medical, Inc. (2009-2013), SpinalMotion, Inc. (2009-2014), and SI-BONE, Inc. (2010-2012).
Managing Director at Skyline Management LLC from 2009 to 2012.
Chief Financial Officer & Treasurer at Sigilon Therapeutics, Inc. from 2019 to 2021.
President of Greyrock Biomedical Advisors Ltd. from 2013 to 2019.
Titles also include Independent Director at Amplitude Healthcare Acquisition Corp., Analyst at Fidelity Management & Research Co. LLC, Senior Vice President at Oppenheimer & Co., Inc., Management Consultant at Bain & Co., Inc., Chief Financial & Operating Officer at Alladapt Immunotherapeutics, Inc., and Chief Financial Officer at Harmony Biosciences Holdings, Inc. in 2026.
Education includes undergraduate studies at Brandeis University and an MBA from Harvard Business School.

Precedenti posizioni note di Glenn Reicin

SocietàPosizioneFine
HARMONY BIOSCIENCES HOLDINGS, INC. Direttore Finanziario/CFO 16/07/2026
SIGILON THERAPEUTICS, INC. Direttore Finanziario/CFO 14/06/2021
Presidente 01/05/2019
Direttore/Membro del Consiglio 01/01/2014
Direttore/Membro del Consiglio 01/01/2013
Vedi nel dettaglio l'esperienza di Glenn Reicin

Formazione di Glenn Reicin

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

97

Relazioni di 1° grado

15

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private15

Finance

Finance

Health Services

Health Technology

Health Technology

Finance

Commercial Services

Finance

Consumer Services

Consumer Services

Health Technology

Health Technology

Finance

Finance

Health Technology

  1. Mercati
  2. Insiders
  3. Glenn Reicin